This is a Validated Antibody Database (VAD) review about human RANTES, based on 10 published articles (read how Labome selects the articles), using RANTES antibody in all methods. It is aimed to help Labome visitors find the most suited RANTES antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RANTES synonym: D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP

Santa Cruz Biotechnology
mouse monoclonal (A-4)
  • other; mouse; 1:100; fig s6b
Santa Cruz Biotechnology RANTES antibody (Santa Cruz, sc-365826) was used in other on mouse samples at 1:100 (fig s6b). Redox Biol (2021) ncbi
mouse monoclonal (C-12)
  • immunohistochemistry; mouse; loading ...; fig 6b
Santa Cruz Biotechnology RANTES antibody (Santa Cruz Biotechnology, sc-373984) was used in immunohistochemistry on mouse samples (fig 6b). Proc Natl Acad Sci U S A (2021) ncbi
Invitrogen
mouse monoclonal (VL1)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, Invitrogen RANTES antibody (Invitrogen, AHC1052) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (VL-1)
  • flow cytometry; human; fig 1
In order to assess the impact of platelet derived glycosaminoglycans on the immobilization of CCL5 on human microvascular endothelial cells, Invitrogen RANTES antibody (CALTAG, VL-1) was used in flow cytometry on human samples (fig 1). BMC Immunol (2008) ncbi
mouse monoclonal (VL1)
  • flow cytometry; human; fig 1
In order to assess the impact of platelet derived glycosaminoglycans on the immobilization of CCL5 on human microvascular endothelial cells, Invitrogen RANTES antibody (CALTAG, VL-1) was used in flow cytometry on human samples (fig 1). BMC Immunol (2008) ncbi
mouse monoclonal (VL1)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss if patients with Crohn's disease and orofacial granulomatosis should be considered as a unique subset, Invitrogen RANTES antibody (BioSource, VL1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Inflamm Bowel Dis (2007) ncbi
mouse monoclonal (VL1)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 1
In order to study the role of platelet microparticles in delivering RANTES and promoting monocyte recruitment, Invitrogen RANTES antibody (Caltag, VL-1) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 1). Arterioscler Thromb Vasc Biol (2005) ncbi
R&D Systems
mouse monoclonal (21445)
  • immunohistochemistry; human; 1:100; loading ...; fig s14a
R&D Systems RANTES antibody (R&D System, MAB278) was used in immunohistochemistry on human samples at 1:100 (fig s14a). Adv Sci (Weinh) (2021) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 2 ug/ml; loading ...; fig 3a
In order to examine the impact of recruited CD8+ T cells on BPH epithelial cells under a low androgen level, Abcam RANTES antibody (Abcam, ab9679) was used in immunohistochemistry - paraffin section on human samples at 2 ug/ml (fig 3a). Sci Rep (2017) ncbi
BD Biosciences
mouse monoclonal (2D5)
  • flow cytometry; human; 1:100; fig s4
BD Biosciences RANTES antibody (BD Pharmingen, 554732) was used in flow cytometry on human samples at 1:100 (fig s4). Cancer Res (2015) ncbi
mouse monoclonal (2D5)
  • flow cytometry; human
BD Biosciences RANTES antibody (BD Pharmingen, 2D5) was used in flow cytometry on human samples . Virol J (2014) ncbi
Articles Reviewed
  1. Ho M, Yen C, Hsieh T, Kao T, Chiu J, Chiang Y, et al. CCL5 via GPX1 activation protects hippocampal memory function after mild traumatic brain injury. Redox Biol. 2021;46:102067 pubmed publisher
  2. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed publisher
  3. Xie L, Yin Y, Benowitz L. Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  4. Yang Y, Hu S, Liu J, Cui Y, Fan Y, Lv T, et al. CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Sci Rep. 2017;7:42893 pubmed publisher
  5. Miranda A, Funes J, Sánchez N, Limia C, Mesa M, Quezada S, et al. Oncogenic Transformation Can Orchestrate Immune Evasion and Inflammation in Human Mesenchymal Stem Cells Independently of Extrinsic Immune-Selective Pressure. Cancer Res. 2015;75:3032-42 pubmed publisher
  6. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed publisher
  7. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed publisher
  8. Weingart C, Nelson P, Krämer B, Mack M. Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells. BMC Immunol. 2008;9:72 pubmed publisher
  9. Freysdottir J, Zhang S, Tilakaratne W, Fortune F. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis. 2007;13:439-45 pubmed
  10. Mause S, von Hundelshausen P, Zernecke A, Koenen R, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005;25:1512-8 pubmed